1. Home
  2. THH vs CLRB Comparison

THH vs CLRB Comparison

Compare THH & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TryHard Holdings Limited Ordinary Shares

THH

TryHard Holdings Limited Ordinary Shares

HOLD

Current Price

$2.64

Market Cap

13.1M

Sector

N/A

ML Signal

HOLD

Logo Cellectar Biosciences Inc.

CLRB

Cellectar Biosciences Inc.

HOLD

Current Price

$2.56

Market Cap

12.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THH
CLRB
Founded
2013
2002
Country
Japan
United States
Employees
116
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.1M
12.0M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
THH
CLRB
Price
$2.64
$2.56
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
284.3K
34.6K
Earning Date
05-19-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$305.05
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.19
$2.20
52 Week High
$56.26
$6.52

Technical Indicators

Market Signals
Indicator
THH
CLRB
Relative Strength Index (RSI) 80.34 51.59
Support Level $0.33 $2.44
Resistance Level $4.99 $2.70
Average True Range (ATR) 0.35 0.13
MACD 0.25 0.01
Stochastic Oscillator 51.67 60.04

Price Performance

Historical Comparison
THH
CLRB

About THH TryHard Holdings Limited Ordinary Shares

Tryhard Holdings Ltd is a Japan-based lifestyle entertainment company offering services across the entertainment and hospitality sectors. Its main businesses include event curation, consultancy and management, sub-leasing of venues, and restaurant operations. The company operates through four segments, with the majority of revenue generated from consultancy and management, which provides club planning, operations, event production, entertainer bookings, and sponsorship services. The event curation segment produces both in-house and client events; the sub-leasing segment rents venues and sub-leases them to clubs; and the restaurants segment operates themed dining outlets that complement its entertainment offerings.

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Share on Social Networks: